Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/17389
Title: Trastuzumab-decorated nanoparticles of biodegradable polymers for targeted small molecule chemotherapy
Authors: SUN BINGFENG
Keywords: Cancer nanotechnology,Nanomedicine,Nanoparticles,Paclitaxel,Docetaxel,Herceptin
Issue Date: 13-Aug-2009
Source: SUN BINGFENG (2009-08-13). Trastuzumab-decorated nanoparticles of biodegradable polymers for targeted small molecule chemotherapy. ScholarBank@NUS Repository.
Abstract: Targeted chemotherapy has been a challenge in Nanomedicine. This PhD work developed two novel drug delivery systems of Trastuzumab-decorated nanoparticles (NPs) of biodegradable polymers for targeted chemotherapy with Taxoids (Paclitaxel and Docetaxel) as model small molecule therapeutics. Trastuzumab (Herceptin®) is a FDA-approved humanized monoclonal antibody drug which is effective for the cancer of human epidermal growth factor receptor-2 (HER2) overexpression. It is also found synergistic with Taxoids. The first system is the paclitaxel-loaded poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) NPs with Trastuzumab physically adhered on the NP surface. The second system is the Docetaxel-loaded NPs of a blend of two novel copolymers. One is poly(lactide)-D-a-tocopheryl polyethylene glycol succinate (PLA-TPGS), which is of ideal hydrophobic-lipophilic balance for high drug encapsulation efficiency and high cellular adhesion, and another is carboxyl group-terminated TPGS (TPGS-COOH), which facilitates the antibody conjugation on the nanoparticle surface. The targeting effect can be quantitatively controlled by adjusting the copolymer blend ratio. The NPs were prepared by a modified solvent extraction/evaporation method and characterized by state-of-the art equipment for their physicochemical and pharmaceutical properties such as size and size distribution, surface morphology, surface chemistry, surface charge, drug encapsulation efficiency, in vitro drug release kinetics. Proof-of-concept in vitro experimental evaluation showed that the Trastuzumab-functionalized NPs have great advantages versus the corresponding nude NPs in cellular uptake and cytotoxicity for cancer cells of HER2 overexpression.
URI: http://scholarbank.nus.edu.sg/handle/10635/17389
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
SunBF.pdf2.83 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

297
checked on Dec 11, 2017

Download(s)

303
checked on Dec 11, 2017

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.